405 related articles for article (PubMed ID: 32368053)
21. RGD-modified PEG-PAMAM-DOX conjugates: in vitro and in vivo studies for glioma.
Zhang L; Zhu S; Qian L; Pei Y; Qiu Y; Jiang Y
Eur J Pharm Biopharm; 2011 Oct; 79(2):232-40. PubMed ID: 21496485
[TBL] [Abstract][Full Text] [Related]
22. In vitro and in vivo evaluation of stimuli-responsive vesicle from PEGylated hyperbranched PAMAM-doxorubicin conjugate for gastric cancer therapy.
Nie J; Wang Y; Wang W
Int J Pharm; 2016 Jul; 509(1-2):168-177. PubMed ID: 27234696
[TBL] [Abstract][Full Text] [Related]
23. Review on the targeted conjugation of anticancer drugs doxorubicin and tamoxifen with synthetic polymers for drug delivery.
Sanyakamdhorn S; Agudelo D; Tajmir-Riahi HA
J Biomol Struct Dyn; 2017 Aug; 35(11):2497-2508. PubMed ID: 27598545
[TBL] [Abstract][Full Text] [Related]
24. pH/enzyme dual sensitive and nucleus-targeting dendrimer nanoparticles to enhance the antitumour activity of doxorubicin.
Wu ZY; Shen JM; Lang H; Yue T; Sun C
Pharm Dev Technol; 2022 Mar; 27(3):357-371. PubMed ID: 35350969
[TBL] [Abstract][Full Text] [Related]
25. Low systemic toxicity nanocarriers fabricated from heparin-mPEG and PAMAM dendrimers for controlled drug release.
Thanh VM; Nguyen TH; Tran TV; Ngoc UP; Ho MN; Nguyen TT; Chau YNT; Le VT; Tran NQ; Nguyen CK; Nguyen DH
Mater Sci Eng C Mater Biol Appl; 2018 Jan; 82():291-298. PubMed ID: 29025661
[TBL] [Abstract][Full Text] [Related]
26. A robust pH-sensitive unimolecular dendritic nanocarrier that enables targeted anti-cancer drug delivery via GLUT transporters.
Kumar P; Paknikar KM; Gajbhiye V
Colloids Surf B Biointerfaces; 2018 Nov; 171():437-444. PubMed ID: 30075419
[TBL] [Abstract][Full Text] [Related]
27. The interaction of dendrimer-doxorubicin conjugates with a model pulmonary epithelium and their cosolvent-free, pseudo-solution formulations in pressurized metered-dose inhalers.
Zhong Q; Humia BV; Punjabi AR; Padilha FF; da Rocha SRP
Eur J Pharm Sci; 2017 Nov; 109():86-95. PubMed ID: 28774811
[TBL] [Abstract][Full Text] [Related]
28. Core-shell tecto dendrimers formed via host-guest supramolecular assembly as pH-responsive intelligent carriers for enhanced anticancer drug delivery.
Wang J; Li D; Fan Y; Shi M; Yang Y; Wang L; Peng Y; Shen M; Shi X
Nanoscale; 2019 Nov; 11(46):22343-22350. PubMed ID: 31728477
[TBL] [Abstract][Full Text] [Related]
29. Novel peptide-dendrimer conjugates as drug carriers for targeting nonsmall cell lung cancer.
Liu J; Liu J; Chu L; Wang Y; Duan Y; Feng L; Yang C; Wang L; Kong D
Int J Nanomedicine; 2010 Dec; 6():59-69. PubMed ID: 21289982
[TBL] [Abstract][Full Text] [Related]
30. RGD peptide-modified multifunctional dendrimer platform for drug encapsulation and targeted inhibition of cancer cells.
He X; Alves CS; Oliveira N; Rodrigues J; Zhu J; Bányai I; Tomás H; Shi X
Colloids Surf B Biointerfaces; 2015 Jan; 125():82-9. PubMed ID: 25437067
[TBL] [Abstract][Full Text] [Related]
31. Redox and pH-responsive degradable micelles for dually activated intracellular anticancer drug release.
Chen W; Zhong P; Meng F; Cheng R; Deng C; Feijen J; Zhong Z
J Control Release; 2013 Aug; 169(3):171-9. PubMed ID: 23306022
[TBL] [Abstract][Full Text] [Related]
32. Transferrin/α-tocopherol modified poly(amidoamine) dendrimers for improved tumor targeting and anticancer activity of paclitaxel.
Bhatt H; Kiran Rompicharla SV; Ghosh B; Torchilin V; Biswas S
Nanomedicine (Lond); 2019 Dec; 14(24):3159-3176. PubMed ID: 31855118
[No Abstract] [Full Text] [Related]
33. Hydrophobic cavity formed by oligopeptide for doxorubicin delivery based on dendritic poly(L-lysine).
Niidome T; Yamauchi H; Takahashi K; Naoyama K; Watanabe K; Mori T; Katayama Y
J Biomater Sci Polym Ed; 2014; 25(13):1362-73. PubMed ID: 25040893
[TBL] [Abstract][Full Text] [Related]
34. PEG-transferrin conjugated TRAIL (TNF-related apoptosis-inducing ligand) for therapeutic tumor targeting.
Kim TH; Jo YG; Jiang HH; Lim SM; Youn YS; Lee S; Chen X; Byun Y; Lee KC
J Control Release; 2012 Sep; 162(2):422-8. PubMed ID: 22824780
[TBL] [Abstract][Full Text] [Related]
35. Development of biodegradable polymeric implants of RGD-modified PEG-PAMAM-DOX conjugates for long-term intratumoral release.
Wang K; Zhang X; Zhang L; Qian L; Liu C; Zheng J; Jiang Y
Drug Deliv; 2015 May; 22(3):389-99. PubMed ID: 24670095
[TBL] [Abstract][Full Text] [Related]
36. Targeted delivery of doxorubicin using stealth liposomes modified with transferrin.
Li X; Ding L; Xu Y; Wang Y; Ping Q
Int J Pharm; 2009 May; 373(1-2):116-23. PubMed ID: 19429296
[TBL] [Abstract][Full Text] [Related]
37. Facile preparation of core cross-linked nanomicelles based on graft copolymers with pH responsivity and reduction sensitivity for doxorubicin delivery.
Chen T; Xiao Y; Lu W; Liu S; Gan L; Yu J; Huang J
Colloids Surf B Biointerfaces; 2018 Jan; 161():606-613. PubMed ID: 29156337
[TBL] [Abstract][Full Text] [Related]
38. Ligand-directed reduction-sensitive shell-sheddable biodegradable micelles actively deliver doxorubicin into the nuclei of target cancer cells.
Zhong Y; Yang W; Sun H; Cheng R; Meng F; Deng C; Zhong Z
Biomacromolecules; 2013 Oct; 14(10):3723-30. PubMed ID: 23998942
[TBL] [Abstract][Full Text] [Related]
39. PEGylated PAMAM dendrimer-doxorubicin conjugate-hybridized gold nanorod for combined photothermal-chemotherapy.
Li X; Takashima M; Yuba E; Harada A; Kono K
Biomaterials; 2014 Aug; 35(24):6576-84. PubMed ID: 24816361
[TBL] [Abstract][Full Text] [Related]
40. Doxorubicin-Bound Hydroxyethyl Starch Conjugate Nanoparticles with pH/Redox Responsive Linkage for Enhancing Antitumor Therapy.
Tan R; Tian D; Liu J; Wang C; Wan Y
Int J Nanomedicine; 2021; 16():4527-4544. PubMed ID: 34276212
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]